Results 1 to 10 of about 39,430 (282)

The allosteric modulation of complement C5 by knob domain peptides. [PDF]

open access: yesElife, 2021
Bovines have evolved a subset of antibodies with ultra-long CDRH3 regions that harbour cysteine-rich knob domains. To produce high affinity peptides, we previously isolated autonomous 3-6 kDa knob domains from bovine antibodies.
Macpherson A   +17 more
europepmc   +10 more sources

Complement C3 and C5 deficiency affects fracture healing. [PDF]

open access: yesPLoS ONE, 2013
There is increasing evidence that complement may play a role in bone development. Our previous studies demonstrated that the key complement receptor C5aR was strongly expressed in the fracture callus not only by immune cells but also by bone cells and ...
Christian Ehrnthaller   +10 more
doaj   +5 more sources

The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria. [PDF]

open access: yesBlood, 2020
Complement C5 inhibition is the standard of care (SoC) for patients with paroxysmal nocturnal hemoglobinuria (PNH) with significant clinical symptoms. Constant and complete suppression of the terminal complement pathway and the high serum concentration ...
Röth A   +27 more
europepmc   +6 more sources

Complement C5 Contributes to Brain Injury After Subarachnoid Hemorrhage. [PDF]

open access: yesTransl Stroke Res, 2020
Previous studies showed that complement activation is associated with poor functional outcome after aneurysmal subarachnoid hemorrhage (SAH). We investigated whether complement activation is underlying brain injury after aneurysmal SAH (n = 7) and if it ...
van Dijk BJ   +14 more
europepmc   +7 more sources

Identification of potent siRNA targeting complement C5 and its robust activity in pre-clinical models of myasthenia gravis and collagen-induced arthritis [PDF]

open access: yesMolecular Therapy: Nucleic Acids, 2023
Complement component 5 (C5), an important molecule in the complement cascade, blockade by antibodies shows clinical efficacy in treating complement-mediated disorders.
Yoshikazu Kuboi   +11 more
doaj   +2 more sources

Inhibition of complement pathway activation with Pozelimab, a fully human antibody to complement component C5.

open access: yesPLoS ONE, 2020
Complement is a key component of the innate immune system. Inappropriate complement activation underlies the pathophysiology of a variety of diseases. Complement component 5 (C5) is a validated therapeutic target for complement-mediated diseases, but the
Adrianna Latuszek   +27 more
doaj   +2 more sources

The role of microglia and complement C5/C5a in the pathogenesis of rhegmatogenous retinal detachment with choroidal detachment [PDF]

open access: yesComputational and Structural Biotechnology Journal
Background: Rhegmatogenous retinal detachment with choroidal detachment (RRDCD) is an uncommon and sight-threatening disorder marked by fast development and significant inflammation.
Huiyan Xu   +5 more
doaj   +2 more sources

Shiga Toxin 2a Binds to Complement Components C3b and C5 and Upregulates Their Gene Expression in Human Cell Lines

open access: yesToxins, 2020
Enterohemorrhagic Escherichia coli (EHEC) infections can cause EHEC-associated hemolytic uremic syndrome (eHUS) via its main virulent factor, Shiga toxins (Stxs). Complement has been reported to be involved in the progression of eHUS.
Sára Kellnerová   +10 more
doaj   +2 more sources

Complement C5 is not critical for the formation of sub-RPE deposits in Efemp1 mutant mice [PDF]

open access: yesScientific Reports, 2021
The complement system plays a role in the formation of sub-retinal pigment epithelial (RPE) deposits in early stages of age-related macular degeneration (AMD).
Donita L. Garland   +2 more
doaj   +2 more sources

Modulator-induced conformational changes in complement C5, implications for function and drug design [PDF]

open access: yesFrontiers in Immunology
BackgroundThe human complement system comprises proteolytic cascades that drive protective inflammatory and cytolytic responses, making it a crucial part of innate immunity.
Andrey Zhivnov   +7 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy